Effect of enalapril on the incidence of retinopathy in normotensive patients with type 2 diabetes

Rita Rachmani, Merav Lidar, Zohar Levy, Mordchai Ravid

Research output: Contribution to journalArticlepeer-review

Abstract

Two hundred and fifty patients with diabetes mellitus type 2, normal blood pressure, normal kidney function and normo- or microalbuminuria were included in two prospective, controlled studies of 5- and 6-year duration. The patients were randomized to receive enalapril 10 mg/day or placebo. Annual opthalmoscopic examinations were performed, and new cases of diabetic retinopathy were recorded. During the study, retinopathy was found in 9/126 (7.1%) patients assigned to enalapril versus 23/124 (18.5%) patients on placebo, an absolute risk reduction of 11.5% (CI 6-27%, P=0.024). We conclude that, in addition to the effects that ACE inhibitors are already known to have on albuminuria, treatment with them may retard diabetic retinopathy. Further studies are needed to establish this effect. (C) 2000 Elsevier Science B.V.

Original languageEnglish
Pages (from-to)48-50
Number of pages3
JournalEuropean Journal of Internal Medicine
Volume11
Issue number1
DOIs
StatePublished - Feb 2000

Keywords

  • Enalapril
  • Retinopathy
  • Type 2 diabetes

Fingerprint

Dive into the research topics of 'Effect of enalapril on the incidence of retinopathy in normotensive patients with type 2 diabetes'. Together they form a unique fingerprint.

Cite this